CDC recommends shorter booster-dose interval for Moderna COVID-19 vaccine
Jan. 11, 2022
The Centers for Disease Control and Prevention (CDC) has recommended shortening to five months the time between the completion of a primary series of Moderna’s COVID-19 vaccine and a booster dose for individuals 18 years of age and older.
The previous interval for the vaccine was six months.
The five-month interval is already in place for the COVID-19 vaccine from Pfizer-BioNTech.
The CDC’s move followed the decision from the U.S. Food and Drug Administration (FDA) to amend the emergency use authorization (EUA) to shorten the booster-interval period for the Moderna vaccine.
